Why did Jaguar LAA buy J&J Laminar AFib assets?

Jaguar LAA, a newly formed medtech, acquired assets from Johnson & Johnson’s Laminar AFib device program for an undisclosed price. The article frames it as a quiet portfolio-shaping move by J&J rather than major M&A, with no disclosed development, regulatory, commercial, or financing details yet.